Brentuximab Intravenous and Tradjenta

• Generic Name: brentuximab
• Dosage Forms: n.a.
• Other Brand Names: Adcetris

Brentuximab injection is used to treat Hodgkin lymphoma, systemic anaplastic large cell lymphoma (sALCL), and primary cutaneous anaplastic large cell lymphoma (pcALCL), which are blood cancers. It is given to patients who have received a bone marrow (autologous stem cell) transplant or other cancer treatments that did not work well.

Brentuximab injection is also used together with other cancer medicines to treat a previously untreated stage III or IV classical Hodgkin lymphoma.

Brentuximab interferes with the growth of cancer cells, which are then destroyed by the body.

Brentuximab is to be given only by or under the direct supervision of your doctor.

• Generic Name: linagliptin
• Dosage Forms: tablet, film coated
• Other Brand Names: Tradjenta

Tradjenta (linagliptin) is an oral diabetes medicine that helps control blood sugar levels. It works by regulating the levels of insulin your body produces after eating.

Tradjenta is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

Tradjenta is not for treating type 1 diabetes.